Translations:Biosimilar/12/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,166 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 09:54, 20 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Biosimilar)
==Background==
Cloning of human genetic material and development of in vitro biological production systems has allowed the production of virtually any [[recombinant DNA]] based biological substance for eventual development of a drug. [[Monoclonal antibody]] technology combined with recombinant DNA technology has paved the way for tailor-made and targeted medicines. [[gene therapy|Gene-]] and [[cell therapy|cell-based]] therapies are emerging as new approaches.

Background

Cloning of human genetic material and development of in vitro biological production systems has allowed the production of virtually any recombinant DNA based biological substance for eventual development of a drug. Monoclonal antibody technology combined with recombinant DNA technology has paved the way for tailor-made and targeted medicines. Gene- and cell-based therapies are emerging as new approaches.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Biosimilar/12/en&oldid=130321"